Clinical Trials Directory

Trials / Unknown

UnknownNCT02177708

Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy

Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy Measured by MR

Status
Unknown
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

There is increasing evidence that the pathophysiology of hepatic encephalopathy (HE) is tightly associated with low-grade cerebral edema. Uptake of ammonia in astrocytes leads to osmotic swelling caused by glutamine formation. Previous studies were performed in covert HE patients or used indirect methods. Methods: The investigators wish to describes quantitative measurement of localized water content using MRI water mapping in a cohort of patients with cirrhosis during an episode of overt HE type C and again after recovery. Furthermore patients with cirrhosis and no history of HE and healthy subjects will be investigated as controls.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2015-06-01
Completion
2015-12-01
First posted
2014-06-30
Last updated
2014-06-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02177708. Inclusion in this directory is not an endorsement.